Director Dealing

Summary by AI BETAClose X

Oakley Capital Investments Limited announced that Director Peter Dubens transferred 7,000,000 Ordinary Shares between two nominee accounts he owns, with no change to his beneficial ownership. Mr. Dubens's total interest in the company remains at 20,166,360 Ordinary Shares, representing 12.14% of the issued share capital. This transaction, which occurred on April 22, 2026, on the London Stock Exchange, is a notification of a director's dealing and does not alter his overall stake in the company.

Disclaimer*

Oakley Capital Investments Limited
24 April 2026
 

24 April 2026

The announcement below is made in relation to the shareholding of Peter Dubens as a PDMR. He has transferred shares between two accounts he owns and his beneficial ownership of the shares has not changed.

 

Oakley Capital Investments Limited

 

Director Dealing

 

Oakley Capital Investments Limited1 (the "Company") announces the following transaction by a Director of the Company:

Peter Dubens, a Director of the Company, has transferred 7,000,000 Ordinary Shares in the Company ("Ordinary Shares"), from a nominee account in Mr Dubens's name to another nominee account in Mr Dubens's name, with no change to the beneficial ownership of the Ordinary Shares. As a result, Mr Dubens's interest in Ordinary Shares of the Company remains at 20,166,360, representing 12.14% percent of the issued share capital. 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Peter Dubens

2

Reason for the notification

 

a)

Position/status

 

Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Oakley Capital Investments Limited

b)

LEI

 

213800KW6MZUK12CQ815

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of 1p each

 

 

 

 

 

BMG670131058

b)

Nature of the transaction

 

Transfer of shares held in one nominee account to another nominee account, each of with are in the name of Mr Dubens

 

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

N/A - transfer only

7,000,000

d)

Aggregated information

 

-        Aggregated volume

 

-      Price

 

 

 

 

N/A (single transaction)

e)

Date of the transaction

 

22 April 2026

f)

Place of the transaction

 

London Stock Exchange, Main Market

 

 

- ends -

 

The announcement above is made in relation to the shareholding of Peter Dubens as a PDMR. He has transferred shares between two accounts he owns and his beneficial ownership of the shares has not changed.

 

For further information please contact:

 

Oakley Capital Limited

+44 20 7766 6900

Steven Tredget, Investor Relations

 

Greenbrook

+44 20 7952 2000

Rob White / Michael Russell / Theo Bryan

 

Deutsche Numis (Financial Adviser & Broker)

+44 20 7260 1000

Nathan Brown / Matt Goss

 

Notes:

LEI Number: 213800KW6MZUK12CQ815

About Oakley Capital Investments Limited ("OCI")

OCI is a closed-ended investment fund trading on the main market of the London Stock Exchange as an Official List Company. OCI aims to provide shareholders with consistent long-term capital growth in excess of the FTSE All-Share Index by providing liquid access to private equity returns through investment in the Oakley Funds.

A video introduction to OCI is available at https://oakleycapitalinvestments.com/videos/

The contents of the OCI website are not incorporated into, and do not form part of, this announcement.

The Oakley Funds

Oakley Capital Private Equity III, Oakley Capital IV, Oakley Capital V, Oakley Capital VI, Oakley Capital Origin and Oakley Capital Origin II are unlisted lower-mid to mid-market private equity funds that aim to provide investors with significant long-term capital appreciation. The investment strategy of the Funds is to focus on buy-out opportunities in industries with the potential for growth, consolidation and performance improvement. The Oakley family of funds also includes Oakley PROfounders Fund III and Oakley Touring Venture Fund, which are venture capital funds focused on investments in entrepreneur-led, disruptive, technology led companies.

Oakley Capital, the Investment Adviser

Founded in 2002, Oakley Capital Limited has demonstrated the repeated ability to source attractive growth assets at attractive prices. To do this it relies on its sector and regional expertise, its ability to tackle transaction complexity and its deal generating entrepreneur network.

Important information

Oakley Capital Investments Limited is admitted to the Official List of the Financial Conduct Authority. Therefore, the Company is required to satisfy the eligibility criteria for admission to listing on the Official List, and is required to comply with the Financial Conduct Authority's Listing Rules, including in relation to transactions with related parties, financial reporting, contents of shareholder circulars and other continuing obligations.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings